IL159811A0 - Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands - Google Patents
Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligandsInfo
- Publication number
- IL159811A0 IL159811A0 IL15981101A IL15981101A IL159811A0 IL 159811 A0 IL159811 A0 IL 159811A0 IL 15981101 A IL15981101 A IL 15981101A IL 15981101 A IL15981101 A IL 15981101A IL 159811 A0 IL159811 A0 IL 159811A0
- Authority
- IL
- Israel
- Prior art keywords
- fused bicyclic
- receptor ligands
- substituted fused
- gabaa receptor
- heteroaryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30553301P | 2001-07-13 | 2001-07-13 | |
| PCT/US2001/022130 WO2002006990A1 (en) | 2000-07-14 | 2001-07-13 | Method and system for providing medical information |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL159811A0 true IL159811A0 (en) | 2004-06-20 |
Family
ID=23181185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15981101A IL159811A0 (en) | 2001-07-13 | 2001-07-12 | Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US6936617B2 (es) |
| EP (1) | EP1406906A1 (es) |
| JP (1) | JP2005505518A (es) |
| KR (1) | KR20040015356A (es) |
| CN (2) | CN100369912C (es) |
| AR (1) | AR036168A1 (es) |
| BR (1) | BR0211124A (es) |
| CA (1) | CA2453554A1 (es) |
| GT (1) | GT200200148A (es) |
| IL (1) | IL159811A0 (es) |
| MX (1) | MXPA04000372A (es) |
| NZ (1) | NZ530992A (es) |
| PA (1) | PA8550401A1 (es) |
| PE (1) | PE20030292A1 (es) |
| UY (1) | UY27380A1 (es) |
| WO (1) | WO2003006471A1 (es) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7482366B2 (en) * | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
| US7053088B2 (en) | 2002-05-22 | 2006-05-30 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
| WO2004014871A1 (en) | 2002-08-08 | 2004-02-19 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
| UA80295C2 (en) | 2002-09-06 | 2007-09-10 | Biogen Inc | Pyrazolopyridines and using the same |
| DE10247271A1 (de) * | 2002-10-10 | 2004-08-26 | Grünenthal GmbH | Substituierte C-Imidazo[1,2-a]pyridin-3-yle |
| ZA200600037B (en) * | 2003-07-25 | 2007-04-25 | Neurogen Corp | Imidazo-pyrimidines and triazolo-pyrimidines: Benzodiazepine receptor ligands |
| PT1648899E (pt) * | 2003-07-25 | 2007-03-30 | Neurogen Corp | Imidazo-pirimidinas e triazolo-pirimidinas: ligandos do receptor de benzodiazepina |
| EP1880998A1 (en) * | 2003-07-25 | 2008-01-23 | Neurogen Corporation | Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands |
| MY139645A (en) | 2004-02-11 | 2009-10-30 | Amgen Inc | Vanilloid receptor ligands and their use in treatments |
| EP1745034A1 (en) | 2004-02-11 | 2007-01-24 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
| CA2555263A1 (en) * | 2004-02-12 | 2005-09-01 | Neurogen Corporation | Imidazo-pyridazines, triazolo-pyridazines and related benzodiazepine receptor ligands |
| WO2006052546A2 (en) * | 2004-11-04 | 2006-05-18 | Neurogen Corporation | Pyrazolylmethyl heteroaryl derivatives |
| WO2006089311A1 (en) | 2005-02-15 | 2006-08-24 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
| US20070155738A1 (en) | 2005-05-20 | 2007-07-05 | Alantos Pharmaceuticals, Inc. | Heterobicyclic metalloprotease inhibitors |
| US7750000B2 (en) * | 2005-09-02 | 2010-07-06 | Bayer Schering Pharma Ag | Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments |
| US7709468B2 (en) * | 2005-09-02 | 2010-05-04 | Abbott Laboratories | Imidazo based heterocycles |
| MX343042B (es) * | 2005-12-23 | 2016-10-21 | Ariad Pharma Inc | Compuestos heteroarilicos biciclicos. |
| EA200870515A1 (ru) * | 2006-05-08 | 2009-06-30 | Ариад Фармасьютикалз, Инк. | Моноциклические гетероарильные соединения |
| JP5273037B2 (ja) * | 2006-05-08 | 2013-08-28 | アリアド・ファーマシューティカルズ・インコーポレイテッド | アセチレン性ヘテロアリール化合物 |
| US20080249305A1 (en) * | 2007-03-27 | 2008-10-09 | Calderwood David J | Novel imidazole based heterocycles |
| EP1974729A1 (en) | 2007-03-28 | 2008-10-01 | Santhera Pharmaceuticals (Schweiz) AG | Substituted imidazopyridine derivates as melanocortin- 4 receptor antagonists |
| EP2072516A1 (en) * | 2007-12-21 | 2009-06-24 | Santhera Pharmaceuticals (Schweiz) AG | Substituted imidazopyridine derivates as Melancortin-4 receptor antagonists |
| WO2009102761A1 (en) | 2008-02-12 | 2009-08-20 | Bristol-Myers Squibb Company | 1,2,3-triazoles as 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| JP5590040B2 (ja) | 2008-11-12 | 2014-09-17 | アリアド・ファーマシューティカルズ・インコーポレイテッド | キナーゼ阻害剤としてのピラジノピラジンおよび誘導体 |
| US10206921B2 (en) | 2009-06-03 | 2019-02-19 | The Regents Of The University Of California | Methods and compositions for treating a subject for central nervous system (CNS) injury |
| EP2298296A1 (en) | 2009-08-25 | 2011-03-23 | CNRS Centre National De La Recherche Scientifique | Composition and method for treating cognitive impairments in down syndrome subjects |
| KR101774035B1 (ko) | 2009-10-30 | 2017-09-01 | 얀센 파마슈티카 엔.브이. | 이미다조［１，２―ｂ］피리다진 유도체 및 ＰＤＥ１０ 저해제로서의 그의 용도 |
| AR080754A1 (es) | 2010-03-09 | 2012-05-09 | Janssen Pharmaceutica Nv | Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10 |
| WO2011153377A2 (en) * | 2010-06-03 | 2011-12-08 | The Regents Of The University Of California | Methods and compositions for treating a subject for central nervous system (cns) injury |
| KR101034040B1 (ko) * | 2010-08-16 | 2011-05-16 | 정동영 | 백업트랙터 |
| US10604523B2 (en) | 2011-06-27 | 2020-03-31 | Janssen Pharmaceutica Nv | 1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives |
| US20150374705A1 (en) | 2012-02-14 | 2015-12-31 | Shanghai Institues for Biological Sciences | Substances for treatment or relief of pain |
| JP6426603B2 (ja) | 2012-06-26 | 2018-11-21 | ヤンセン ファーマシューティカ エヌ．ベー． | 神経障害または代謝障害の治療に使用するための、１−アリール−４−メチル−［１，２，４］トリアゾロ［４，３−ａ］−キノキサリン化合物などのＰＤＥ２阻害剤とＰＤＥ１０阻害剤との組合せ |
| EP2869822B1 (en) | 2012-07-09 | 2016-09-14 | Janssen Pharmaceutica, N.V. | Inhibitors of phosphodiesterase 10 enzyme |
| CA2815506C (en) | 2012-12-12 | 2018-12-11 | Ariad Pharmaceuticals, Inc. | Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide mono hydrochloride |
| US9527835B2 (en) | 2014-02-13 | 2016-12-27 | Incyte Corporation | Cyclopropylamines as LSD1 inhibitors |
| CN106488915B (zh) | 2014-02-13 | 2020-10-02 | 因赛特公司 | 作为lsd1抑制剂的环丙胺 |
| TW201613860A (en) | 2014-02-13 | 2016-04-16 | Incyte Corp | Cyclopropylamines as LSD1 inhibitors |
| SG10201806849WA (en) | 2014-02-13 | 2018-09-27 | Incyte Corp | Cyclopropylamines as lsd1 inhibitors |
| US9758523B2 (en) | 2014-07-10 | 2017-09-12 | Incyte Corporation | Triazolopyridines and triazolopyrazines as LSD1 inhibitors |
| TW201613925A (en) | 2014-07-10 | 2016-04-16 | Incyte Corp | Imidazopyrazines as LSD1 inhibitors |
| US9695167B2 (en) | 2014-07-10 | 2017-07-04 | Incyte Corporation | Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors |
| US9695168B2 (en) | 2014-07-10 | 2017-07-04 | Incyte Corporation | Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors |
| SI3240785T1 (sl) | 2014-12-29 | 2021-11-30 | THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER, NATIONAL INSTITUTES OF HEALTH | Malomolekulski zaviralci laktat dehidrogenaze in postopki za uporabo le-teh |
| US9944647B2 (en) | 2015-04-03 | 2018-04-17 | Incyte Corporation | Heterocyclic compounds as LSD1 inhibitors |
| UA126277C2 (uk) | 2015-08-12 | 2022-09-14 | Інсайт Корпорейшн | Солі інгібітору lsd1 |
| BR112018071585B1 (pt) | 2016-04-22 | 2024-01-02 | Incyte Corporation | Formulações de um inibidor de lsd1, seus usos e método de preparação das mesmas |
| US10968200B2 (en) | 2018-08-31 | 2021-04-06 | Incyte Corporation | Salts of an LSD1 inhibitor and processes for preparing the same |
| AU2019387370A1 (en) | 2018-11-30 | 2021-06-10 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
| CN111662270A (zh) * | 2019-03-05 | 2020-09-15 | 中国医学科学院药物研究所 | 碘同位素标记苄苯醚衍生物、及其制法和药物组合物与用途 |
| KR20260004434A (ko) * | 2023-04-24 | 2026-01-08 | 상하이 에스아이엠알 바이오테크놀로지 컴퍼니 리미티드 | 이미다조피리딘 또는 이미다조피라진 화합물, 이의 제조 방법, 약학 조성물 및 용도 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989001333A1 (en) * | 1987-08-07 | 1989-02-23 | The Australian National University | IMIDAZO[1,2-b]PYRIDAZINES |
| WO1996034866A1 (en) * | 1995-05-01 | 1996-11-07 | Fujisawa Pharmaceutical Co., Ltd. | Imidazo 1,2-a pyridine and imidazo 1,2-a pyridezine derivatives and their use as bone resorption inhibitors |
| GB9801538D0 (en) | 1998-01-23 | 1998-03-25 | Merck Sharp & Dohme | Pharmaceutical product |
| GB9805559D0 (en) | 1998-03-16 | 1998-05-13 | Merck Sharp & Dohme | A combination of therapeutic agents |
| GB9805561D0 (en) | 1998-03-16 | 1998-05-13 | Merck Sharp & Dohme | A combination of therapeutic agents |
| GB9805557D0 (en) | 1998-03-16 | 1998-05-13 | Merck Sharp & Dohme | A combination of therapeutic agents |
| US6271241B1 (en) | 1999-04-02 | 2001-08-07 | Neurogen Corporation | Cycloalkyl and aryl fused aminoalkyl-imidazole derivatives: modulators and GLP-1 receptors |
| US6380210B1 (en) | 1999-04-02 | 2002-04-30 | Neurogen Corporation | Heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors |
| US6358949B1 (en) | 1999-04-02 | 2002-03-19 | Neurogen Corporation | Aryl and hetroaryl fused aminoalkyl-imidazole derivatives: selective modulators of bradykinin B2 receptors |
| WO2001053298A1 (en) | 2000-01-18 | 2001-07-26 | Neurogen Corporation | Imidazopyridines and related azacyclic derivatives as selective modulators of bradykinin b2 receptors |
| US6552037B2 (en) * | 2000-06-30 | 2003-04-22 | Neurogen Corporation | 2-Substituted imidazo[1,2-A]pyridine derivatives |
| PA8535601A1 (es) | 2000-12-21 | 2002-11-28 | Pfizer | Derivados benzimidazol y piridilimidazol como ligandos para gabaa |
-
2001
- 2001-07-12 IL IL15981101A patent/IL159811A0/xx unknown
-
2002
- 2002-07-11 GT GT200200148A patent/GT200200148A/es unknown
- 2002-07-12 CN CNB028166965A patent/CN100369912C/zh not_active Expired - Fee Related
- 2002-07-12 CA CA002453554A patent/CA2453554A1/en not_active Abandoned
- 2002-07-12 AR ARP020102628A patent/AR036168A1/es unknown
- 2002-07-12 BR BR0211124-1A patent/BR0211124A/pt not_active IP Right Cessation
- 2002-07-12 JP JP2003512241A patent/JP2005505518A/ja active Pending
- 2002-07-12 MX MXPA04000372A patent/MXPA04000372A/es active IP Right Grant
- 2002-07-12 PA PA20028550401A patent/PA8550401A1/es unknown
- 2002-07-12 WO PCT/US2002/022130 patent/WO2003006471A1/en not_active Ceased
- 2002-07-12 PE PE2002000626A patent/PE20030292A1/es not_active Application Discontinuation
- 2002-07-12 NZ NZ530992A patent/NZ530992A/en unknown
- 2002-07-12 CN CNA2008100019411A patent/CN101220027A/zh active Pending
- 2002-07-12 KR KR10-2004-7000563A patent/KR20040015356A/ko not_active Ceased
- 2002-07-12 EP EP02749983A patent/EP1406906A1/en not_active Withdrawn
- 2002-07-12 US US10/194,852 patent/US6936617B2/en not_active Expired - Fee Related
- 2002-07-12 UY UY27380A patent/UY27380A1/es not_active Application Discontinuation
-
2005
- 2005-08-29 US US11/214,345 patent/US20060014746A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA04000372A (es) | 2004-07-23 |
| CN100369912C (zh) | 2008-02-20 |
| CN1553916A (zh) | 2004-12-08 |
| US20030207885A1 (en) | 2003-11-06 |
| US20060014746A1 (en) | 2006-01-19 |
| GT200200148A (es) | 2003-05-15 |
| PA8550401A1 (es) | 2004-02-07 |
| JP2005505518A (ja) | 2005-02-24 |
| AR036168A1 (es) | 2004-08-18 |
| PE20030292A1 (es) | 2003-04-03 |
| KR20040015356A (ko) | 2004-02-18 |
| NZ530992A (en) | 2005-06-24 |
| UY27380A1 (es) | 2003-02-28 |
| US6936617B2 (en) | 2005-08-30 |
| WO2003006471A1 (en) | 2003-01-23 |
| BR0211124A (pt) | 2004-06-29 |
| CN101220027A (zh) | 2008-07-16 |
| CA2453554A1 (en) | 2003-01-23 |
| EP1406906A1 (en) | 2004-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL159811A0 (en) | Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands | |
| IL154310A0 (en) | Heterocyclic compounds as ligands of the gabaa receptor | |
| PL374544A1 (en) | Imidazo fused compounds | |
| EP1831221A4 (en) | CHIRAL COMPOUNDS 1,2 IMIDAZO 4,5-C SUBSTITUTED FUSED CORE | |
| CZ2004408A3 (cs) | Azabicyklicky substituované kondenzované heteroarylsloučeniny | |
| EP1831226A4 (en) | CHIRAL COMPOUNDS WITH CYCLE 1,2 IMIDAZO 4,5-c FUSIONNE | |
| AU2002348503A8 (en) | Quinuclidine-substituted heteroaromatic compounds as ligands at nicotic acetylcholine receptors | |
| HUS1300078I1 (hu) | Biciklusos heteroaril-vegyületek | |
| AU2001252574A1 (en) | Novel bicyclic compounds | |
| DE60021262D1 (de) | Bizyklische heteroaromatische verbindungen als lh-agonisten | |
| AU2002323787A1 (en) | Spiro compounds | |
| AP2002002567A0 (en) | Triamide-substituted heterobicyclic compounds | |
| IL161787A0 (en) | Sulfonamido substituted imidazopyridines | |
| IL181848A0 (en) | Substituted bicyclic imidazo-3-yl-amine compounds | |
| EP1687002A4 (en) | CONDENSED HETEROCYCLIC COMPOUNDS | |
| IL174283A0 (en) | Fused heterocyclic compounds | |
| PL1636192T3 (pl) | Związki heteroarylowe podstawione grupą 3-alkilidenohydrazynową jako aktywatory receptora trombopoetyny | |
| IL161409A0 (en) | Methods for ligand discovery | |
| PL373953A1 (en) | 7-amino-benzothiazole derivatives as adenosine receptor ligands | |
| AU2002333655A1 (en) | Bicyclic heterocycles as rxr ligands | |
| IL161120A (en) | Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1 | |
| AU2002353910A1 (en) | Process for the preparation of aniline-derived thyroid receptor ligands | |
| HRP20040672A2 (en) | Triazolo-quinolin derivatives useful as adenosine receptor ligands | |
| AU1392902A (en) | Bicyclic heteroaromatic compounds | |
| IL161836A0 (en) | Aryl fused azapolycyclic compounds |